News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Chronic Kidney Disease Patients Fare Well in Statin Trial, Harvard Medical School And Brigham and Women's Hospital Study



3/19/2010 7:36:27 AM

ATLANTA -- Chronic kidney disease patients in the landmark JUPITER trial achieved a 44% reduction in mortality if they were assigned to the potent cholesterol-lowering agent rosuvastatin (Crestor) when compared with patients who were on placebo, researchers said here.

Read at MedPageToday


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES